News

We are proud to announce that our manufacturing facility in Eysins, Switzerland has been granted ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) certifications for the design, development, production, and distribution of in-vitro diagnostic test kits and reagents for

At AliveDx, our mission is to empower diagnostic insights, transform patient care, and innovate for life. We are excited and proud to announce AliveDx has received IVDR-CE mark certification for its multiplexed MosaiQ AiPlex™ CD microarray immunoassay, designed to improve

Alba Bioscience Inc., part of the AliveDx group, is pleased to announce a distribution agreement with RAF Solutions LA, Inc. to bring its high-quality blood bank reagents to the Latin American market. This strategic partnership reinforces Alba’s commitment to expanding

AliveDx Suisse S.A. and Tabrane Pharmaceuticals (PVT) Limited have signed a distribution agreement, which will enable Tabrane Pharmaceuticals to distribute the MosaiQ® solution in Sri Lanka. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and

We are proud to announce that our abstract B-073, titled:  “Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay Prototype for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases” has been awarded the ADLM 2024 Industry

AliveDx Suisse S.A. and Kyungil Hi-tec INC have signed an exclusive distribution agreement, which will enable Kyungil Hi-tec to distribute the MosaiQ® solution in South Korea. The distribution agreement takes effect immediately. This strategic partnership with an important partner in

AliveDx Suisse S.A. and PZ Cormay S.A. have signed a distribution agreement, which will enable PZ Cormay to distribute the MosaiQ® solution in Poland. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and presence across

We are excited to announce our participation in the upcoming ADLM 2024 Congress, from July 30 to August 1, 2024, in Chicago, USA. Visit us at booth #4055 to learn more about our high-quality blood bank reagents, and the latest

AliveDx Suisse S.A. and Prolab IVD S.R.L. have signed a distribution agreement, which will enable Prolab to distribute the MosaiQ® solution in Romania. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening its global footprint and

AliveDx Suisse S.A. and BioAnalytica S.A. have signed a distribution agreement, which will enable BioAnalytica to distribute the MosaiQ® solution in Greece and Cyprus. The distribution agreement takes effect immediately. This strategic partnership underscores AliveDx’s commitment to expanding its geographical